ConductScience.org, home

Paper604361

Granuloma formation in patients after injection of methanol extraction residue (MER-GCG).

Bartal A and 3 others. J Clin Pathol, 1977. Cited by 6 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Granuloma formation in patients after injection of methanol extraction residue (MER-GCG). Papers, record 604361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/604361

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Granuloma formation in patients after injection of methanol extraction residue (MER-GCG).
PubMed
Journal
J Clin Pathol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.36
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bartal AA
2Kerner HH
3Cohen YY
4Robinson EE

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
GranulomaMajor topic
Skin DiseasesMajor topic
Adult
Aged
Female
Humans
Lymph Nodes
Male
Middle Aged
Neoplasms
Skin

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1791,387Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications.Biomedicine1976https://conductscience.org/library/papers/791387PubMed
24,633,406Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli.Natl Cancer Inst Monogr1972https://conductscience.org/library/papers/4633406PubMed
34,126,618Granulomatous hepatitis: a complication of B.C.G. immunotherapy.Lancet1973https://conductscience.org/library/papers/4126618PubMed
44,598,691BCG and cancer.N Engl J Med1974https://conductscience.org/library/papers/4598691PubMed
548,944Effect of intravenous B.C.G. in guineapigs and pertinence to cancer immunotherapy in man.Lancet1975https://conductscience.org/library/papers/48944PubMed
6803,877Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.Cell Immunol1975https://conductscience.org/library/papers/803877PubMed
71,100,088A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.Br J Cancer1975https://conductscience.org/library/papers/1100088PubMed
8770,333Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.Infect Immun1976https://conductscience.org/library/papers/770333PubMed
9947,509Observations following Corynebacterium parvum administration to patients with advanced malignancy. a phase I study.Cancer1976https://conductscience.org/library/papers/947509PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/604361

GET https://conductscience.org/api/papers/v1/604361/authors